Detection and Activation of CD4+ T cells with Low Affinity TCRs
低亲和力 TCR 的 CD4 T 细胞的检测和激活
基本信息
- 批准号:10570243
- 负责人:
- 金额:$ 38.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-03-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Adoptive TransferAffinityAntibodiesAntigen ReceptorsAutoimmunityB-Cell LeukemiaBacteriaBindingCD4 AntigensCD4 Positive T LymphocytesCNS autoimmune diseaseCell ProliferationCellsClonal DeletionComplexCytotoxic T-LymphocytesDendritic CellsDetectionEffector CellEpitopesFlow CytometryFluorochromeGenerationsGoalsHelper-Inducer T-LymphocyteHistocompatibility Antigens Class IIImmune responseImmunityImmunotherapyIn VitroInfectionKnowledgeLabelLigandsListeria monocytogenesLiteratureMalignant NeoplasmsMediatingMemoryMicrobeModelingMolecular EvolutionPeptidesPhagosomesPhysiologicalPlayPositioning AttributeReagentReceptor SignalingRoleSalmonella entericaSignal TransductionT-LymphocyteTestingTh1 CellsThymus GlandTissuesVaccinationVaccinesacute infectioncellular transductionchronic infectioncytotoxicimprovedinnovationleukemianeoplasm immunotherapynew therapeutic targetoligodendrocyte-myelin glycoproteinpathogenreceptor bindingresponsesecondary lymphoid organtooltumor
项目摘要
Project Summary/Abstract
CD4+ helper T (Th) cells are responsible for host immunity to phagosomal pathogens and augment antibody
and cytotoxic T cell-mediated responses. They also cause autoimmunity and can participate in immune
responses to tumors. Th cells carry out these functions by using antigen receptors (TCRs) to recognize
epitopes consisting of peptides (p) bound to major histocompatibility complex class II molecules (MHCII)
displayed on various host cells. Fluorochrome-labeled p:MHCII tetramers and flow cytometry have been critical
tools for studying immune responses by epitope-specific polyclonal Th cells. It has become clear, however,
that p:MHCII tetramers do not detect TCRs at the low end of the relevant affinity spectrum. This limitation has
created a knowledge gap about the roles that Th cells with low-affinity TCRs play in immune responses to
infections and cancer. We hypothesized that p:MHCII tetramers underperform because their stalk regions do
not bind to CD4 molecules on Th cells. We used molecular evolution to select an MHCII molecule with
improved CD4 binding (MHCII-4E) and found that p:MHCII-4E tetramers are superior to conventional reagents
at detecting Th cells with low affinity TCRs. We will use these innovative reagents to identify the roles that Th
cells with low affinity TCRs play in immune responses to persistent and chronic infections, and an autoimmune
disease of the central nervous system. We will also test a p:MHCII-4E-based vaccine in a B cell leukemia
model. Completion of these aims will fill basic knowledge gaps about the composition of Th repertoires for self
and foreign epitopes and provide proof of principle for new therapies targeted to low affinity Th cells.
项目总结/摘要
CD 4+辅助性T(Th)细胞负责宿主对吞噬体病原体的免疫并增加抗体
和细胞毒性T细胞介导的应答。它们还引起自身免疫,并可参与免疫应答。
对肿瘤的反应。Th细胞通过使用抗原受体(TCR)识别
表位由与主要组织相容性复合体II类分子(MHCII)结合的肽(p)组成
展示在各种宿主细胞上。荧光染料标记的p:MHCII四聚体和流式细胞术已经成为关键
用于研究表位特异性多克隆Th细胞的免疫应答的工具。然而,很明显,
p:MHCII四聚体不能检测到相关亲和谱低端的TCR。这种局限性
造成了关于具有低亲和力TCR的Th细胞在免疫应答中所起作用的知识空白,
感染和癌症。我们假设p:MHCII四聚体表现不佳是因为它们的茎区
不与Th细胞上的CD 4分子结合。我们使用分子进化来选择MHCII分子,
改进的CD 4结合(MHCII-4 E),并发现p:MHCII-4 E四聚体优于常规试剂上级
检测具有低亲和力TCR的Th细胞。我们将使用这些创新的试剂来确定Th
具有低亲和力TCR的细胞在对持续性和慢性感染的免疫应答中起作用,
中枢神经系统疾病。我们还将在B细胞白血病中测试基于p:MHCII-4 E的疫苗
模型这些目标的完成将填补有关Th曲目组成的基本知识空白
和外源表位,并为靶向低亲和力Th细胞的新疗法提供原理证明。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Marc Kevin Jenkins其他文献
Marc Kevin Jenkins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Marc Kevin Jenkins', 18)}}的其他基金
Detection and Activation of CD4+ T cells with Low Affinity TCRs
低亲和力 TCR 的 CD4 T 细胞的检测和激活
- 批准号:
10348758 - 财政年份:2019
- 资助金额:
$ 38.32万 - 项目类别:
相似海外基金
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
- 批准号:
10549640 - 财政年份:2023
- 资助金额:
$ 38.32万 - 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
- 批准号:
2750554 - 财政年份:2021
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
- 批准号:
61319 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10013588 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
- 批准号:
20K07009 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
- 批准号:
10603473 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
- 批准号:
2342674 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
- 批准号:
10117194 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
- 批准号:
10115604 - 财政年份:2020
- 资助金额:
$ 38.32万 - 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
- 批准号:
10294224 - 财政年份:2018
- 资助金额:
$ 38.32万 - 项目类别: